期刊文献+

2-位亚甲基头孢类抗生素的设计、合成与生物活性

Design, synthesis and bioactivity of 2-methylene-cephalosporin antibiotics
原文传递
导出
摘要 目的设计合成具有抗菌活性的2-位亚甲基头孢类抗生素。方法以7-苯乙酰氨基-3-氯甲基-头孢-3-烯-4-羧酸对甲氧基苄酯(GCLE)为起始原料,经Mannich反应、酶解、缩合等反应制得2-位亚甲基头孢类抗生素。通过微量稀释法测定了其对标准金黄色葡萄球菌、标准肺炎克雷伯杆菌的最小抑菌浓度。结果合成了4个新化合物8a~8d,利用1H-NMR和MS确证了结构,初步测试显示较好的抗菌活性。结论初步生物活性试验结果显示化合物8a、8b和8d对标准金黄色葡萄球菌的抗菌活性均与头孢克肟和头孢地尼相当,化合物8a、8b对标准肺炎克雷伯杆菌的抗菌活性与头孢克肟和头孢地尼相当。 Objective To design and synthesize 2-methylene-cephalosporin antibiotics for antibacterial activity. Methods 2-methylene- cephalosporin antibiotics were synthesized from the starting material GCLE via Mannich reaction, enzymolysis, and condensation, etc. The study on antibacterial activity was carried out using micro-dilution to detect the minimum inhibitory concentrations (MIC) on standard Staphylococcus aureus and standard Bacillus canalis capsulatus. Results The four novel compounds were synthesized. All the compounds were characterized by 1 H-NMR and MS. The preliminary test showed that the compound had good antibacterial activities. Conclusion Through the preliminary bioactivity test, the results show that the antibacterial activities of the compounds 8a, 8b, and 8d on standard Staphylococcus aureus are the same to those of cefixime and cefdinir, and the antibacterial activities of the compounds 8a and 8b on standard Bacillus canalis capsulatus are the same to those of cefixime and cefdinir.
出处 《现代药物与临床》 CAS 2013年第4期487-490,共4页 Drugs & Clinic
基金 天津市科技攻关计划重大科技项目(05YFGDGX09500)
关键词 2-位亚甲基头孢类抗生素 MANNICH反应 酶解 抗菌活性 2-methylene-cephalosporin Mannich reaction enzymolysis antibacterial activity
  • 相关文献

参考文献9

二级参考文献41

  • 1张士国,李红,杨频.双环β-内酰胺抗生素分子活性构象的理论研究[J].高等学校化学学报,1995,16(11):1669-1671. 被引量:4
  • 2TAMAS E G, LASZLO T, SZABOLCS S, et al. A very mild and quantitative oxidation of cephalosporins with dimethyldioxirane [ J ]. Tetrahedron Lett, 1995, 36(39) :7111 -7114.
  • 3TAMAS E G. Mannich reaction of cephalosporin sulphoxides and sulphones with imonium salts. An improved synthesis of 2-methylene-cephalosporins [ J ]. Synth Commun, 1992,22 (20) :2979 - 2986.
  • 4DOUGLAS O S. Tricyclic cephalosporins: US,3907785 [P]. 1975 -09 -23.
  • 5BARENDSE N,Van Der KLEIN P,VERWEIJ J,et al. Synthesis of the fl-lactamase indicators cefesone and nitrocefin [ J]. Synthesis, 1998,30(2) : 145 - 147.
  • 6王祖陶,化学学报,1985年,43卷,873页
  • 7任境清,北京大学学报,1982年,3期,49页
  • 8Imming. P, Klar B, Dix D. Hydrolytic stability versus ring size in laetams:implications for the development of lactam antibiotics and other sefine protease inhibitors. Jounral of Medicinal Chemistry,2000,43(22) :4328.
  • 9Heinze-Krauss. I, Angehm P, Chamas R L, et al . Struture-based design of β-lactamase inhibitors. 1. Synthesis and evaluation of bridged monobactams.Jounral of Medicinal Chemistry, 1998,41 : 3961.
  • 10Albrecht H A, Beskid G, Christenson J G, et al . Dual-Action Cephalosporins Incorporating a 3'-Tertiary-Amine-Linked Quinolone. Jourtral of Medicinal Chemistry, 1994,37(3) :400.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部